![]() |
|
|
Vol. 17, Issue 10, 4187-4199, October 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



*Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal;
Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Charlestown, MA 02129; and
Departamento de Ciências da Saúde, Universidade da Madeira, 9000-390 Funchal, Portugal
Submitted January 13, 2006;
Revised July 10, 2006;
Accepted July 11, 2006
Monitoring Editor: Karsten Weis
U2AF is a heterodimeric splicing factor composed of a large (U2AF65) and a small (U2AF35) subunit. In humans, alternative splicing generates two U2AF35 variants, U2AF35a and U2AF35b. Here, we used RNA interference to specifically ablate the expression of each isoform in HeLa cells. Our results show that knockdown of the major U2AF35a isoform reduced cell viability and impaired mitotic progression, leading to accumulation of cells in prometaphase. Microarray analysis revealed that knockdown of U2AF35a affected the expression level of
500 mRNAs, from which >90% were underrepresented relative to the control. Among mRNAs underrepresented in U2AF35a-depleted cells we identified an essential cell cycle gene, Cdc27, for which there was an increase in the ratio between unspliced and spliced RNA and a significant reduction in protein level. Furthermore, we show that depletion of either U2AF35a or U2AF35b altered the ratios of alternatively spliced isoforms of Cdc25B and Cdc25C transcripts. Taken together our results demonstrate that U2AF35a is essential for HeLa cell division and suggest a novel role for both U2AF35 protein isoforms as regulators of alternative splicing of a specific subset of genes.
This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E06-01-0036) on July 19, 2006.
Address correspondence to: Maria Carmo-Fonseca (carmo.fonseca{at}fm.ul.pt)
This article has been cited by other articles:
![]() |
R. S. C. Cosme, Y. Yamamura, and Q. Tang Roles of Polypyrimidine Tract Binding Proteins in Major Immediate-Early Gene Expression and Viral Replication of Human Cytomegalovirus J. Virol., April 1, 2009; 83(7): 2839 - 2850. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Andersen and N. Tapon Drosophila MFAP1 Is Required for Pre-mRNA Processing and G2/M Progression J. Biol. Chem., November 7, 2008; 283(45): 31256 - 31267. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Grosso, A. Q. Gomes, N. L. Barbosa-Morais, S. Caldeira, N. P. Thorne, G. Grech, M. von Lindern, and M. Carmo-Fonseca Tissue-specific splicing factor gene expression signatures Nucleic Acids Res., September 1, 2008; 36(15): 4823 - 4832. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Izquierdo Fas Splicing Regulation during Early Apoptosis Is Linked to Caspase-mediated Cleavage of U2AF65 Mol. Biol. Cell, August 1, 2008; 19(8): 3299 - 3307. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rino, J. M. P. Desterro, T. R. Pacheco, T. W. J. Gadella Jr., and M. Carmo-Fonseca Splicing Factors SF1 and U2AF Associate in Extraspliceosomal Complexes Mol. Cell. Biol., May 1, 2008; 28(9): 3045 - 3057. [Abstract] [Full Text] [PDF] |
||||